Aethlon Medical (AEMD) Stock Price, Quote & News

Latest News on AEMD

Dec 20, 2024, 8:01 AM EST - 4 weeks ago

Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu

Nov 14, 2024, 8:00 AM EST - 2 months ago

Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally

Nov 13, 2024, 7:58 PM EST - 2 months ago

Aethlon Medical, Inc. (AEMD) Q2 2025 Earnings Call Transcript

Nov 13, 2024, 4:15 PM EST - 2 months ago

Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update

Nov 12, 2024, 8:00 AM EST - 2 months ago

Innovative Medical Technology Advances with First Patient Enrollments

Nov 11, 2024, 8:01 AM EST - 2 months ago

Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia

Nov 6, 2024, 8:01 AM EST - 2 months ago

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024

Oct 8, 2024, 8:01 AM EDT - 3 months ago

Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit

Sep 19, 2024, 10:00 AM EDT - 4 months ago

Immunotherapy Clinical Trials - A New Approach to Treating Cancer

Sep 19, 2024, 8:01 AM EDT - 4 months ago

Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India

Sep 17, 2024, 8:01 AM EDT - 4 months ago

Aethlon Medical to Present at Virtual Investor Conferences in September

Sep 17, 2024, 7:30 AM EDT - 4 months ago

Innovation Driving Cancer's Solid Tumors Market

Sep 16, 2024, 8:01 AM EDT - 4 months ago

Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial

Sep 13, 2024, 8:35 AM EDT - 4 months ago

Aethlon Medical to Present at the Life Sciences Investor Forum September 19th

Aug 27, 2024, 8:01 AM EDT - 5 months ago

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys

Aug 14, 2024, 6:45 PM EDT - 5 months ago

Aethlon Medical, Inc. (AEMD) Q1 2025 Earnings Call Transcript

Aug 14, 2024, 4:15 PM EDT - 5 months ago

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update

Aug 12, 2024, 9:01 AM EDT - 5 months ago

The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors

Aug 12, 2024, 8:01 AM EDT - 5 months ago

Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial

Aug 6, 2024, 9:12 AM EDT - 5 months ago

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024

Jun 27, 2024, 6:37 PM EDT - 7 months ago

Aethlon Medical, Inc. (AEMD) Q4 2024 Earnings Call Transcript

Jun 27, 2024, 4:15 PM EDT - 7 months ago

Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update

Jun 21, 2024, 8:01 AM EDT - 7 months ago

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024

Jun 20, 2024, 7:00 AM EDT - 7 months ago

What's Next in Treatments for Cancer Patients with Solid Tumors?

Jun 18, 2024, 8:01 AM EDT - 7 months ago

Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial

Jun 7, 2024, 8:00 AM EDT - 8 months ago

The Hunt for Virus Treatments Continues Post Covid-19

Jun 3, 2024, 9:05 AM EDT - 8 months ago

Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVID

Jun 3, 2024, 8:01 AM EDT - 8 months ago

Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies

May 15, 2024, 9:15 AM EDT - 8 months ago

Aethlon Medical Announces Pricing of $4.7 Million Public Offering

May 10, 2024, 8:01 AM EDT - 9 months ago

Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma

Feb 21, 2024, 8:01 AM EST - 11 months ago

Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices

Feb 14, 2024, 9:17 PM EST - 1 year ago

Aethlon Medical, Inc. (AEMD) Q3 2024 Earnings Call Transcript

Feb 14, 2024, 4:15 PM EST - 1 year ago

Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update

Feb 7, 2024, 8:00 AM EST - 1 year ago

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024

Nov 14, 2023, 10:01 PM EST - 1 year ago

Aethlon Medical, Inc. (AEMD) Q2 2024 Earnings Call Transcript

Nov 14, 2023, 4:15 PM EST - 1 year ago

Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update

Nov 13, 2023, 8:01 AM EST - 1 year ago

Aethlon Medical Announces Appointment of James B. Frakes, M.B.A.

Nov 6, 2023, 8:01 AM EST - 1 year ago

Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023

Oct 10, 2023, 8:01 AM EDT - 1 year ago

Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in Oncology

Oct 4, 2023, 8:01 AM EDT - 1 year ago

Aethlon Announces Reverse Stock Split

Aug 30, 2023, 8:01 AM EDT - 1 year ago

Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Aug 10, 2023, 9:17 PM EDT - 1 year ago

Aethlon Medical, Inc. (AEMD) Q1 2024 Earnings Call Transcript

Aug 10, 2023, 4:15 PM EDT - 1 year ago

Aethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate Update

Aug 3, 2023, 8:01 AM EDT - 1 year ago

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023

Jul 24, 2023, 8:01 AM EDT - 1 year ago

Aethlon Medical Signs Collaboration Agreement with 34 Lives to Evaluate the Ability of the Hemopurifier® to Expand the Utility of Unused, Donated Kidneys for Transplant

Jul 6, 2023, 2:17 PM EDT - 1 year ago

Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of Directors

Jun 28, 2023, 6:28 PM EDT - 1 year ago

Aethlon Medical, Inc. (AEMD) Q4 2023 Earnings Call Transcript

Jun 28, 2023, 4:15 PM EDT - 1 year ago

Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update

Jun 22, 2023, 8:01 AM EDT - 1 year ago

Aethlon Medical to Release Fourth Quarter and Year End Financial Results and Host Conference Call on June 28, 2023

Jun 21, 2023, 8:01 AM EDT - 1 year ago

Market Cap	9.98M
Revenue (ttm)	0.00
Net Income (ttm)	-12.21M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	1,225,000
Avg Vol	3,897,984
Day's Range	N/A - N/A
Shares Out	13.96M
Stochastic %K	13%
Beta	1.61
Analysts	Sell
Price Target	$3.85